Clinical Trials Browser

Observational × Docetaxel × Tumor-Agnostic × Clear all

NCT01251653 2016-05-30

A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel

94 enrolled 33 charts

Neoplasms